Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
Maria Mironova(National Institutes of Health), Maria F. Lopes‐Virella(Ralph H. Johnson VA Medical Center), Richard L. Klein(AdventHealth Tampa), Gabriel Virella(Ralph H. Johnson VA Medical Center)
Cited by 97
Related Papers
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726
<i>Chlamydophila pneumoniae</i> Induces ICAM-1 Expression in Human Aortic Endothelial Cells via Protein Kinase C–Dependent Activation of Nuclear Factor-κB
|Circulation Research|2003|33
Hepatitis B Vaccine: Four Decades on
|Vaccines|2024|26
Granulomatous liver diseases
|Hepatology Communications|2024|25
Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies
|Current Hepatology Reports|2024|15